Elevance Health Inc (NYSE:ELV) shares, rose in value, with the stock price down by -0.45% to the previous day’s close as strong demand from buyers drove the stock to $537.26.
Actively observing the price movement in the last trading, the stock closed the session at $539.68. The value of beta (5-year monthly) was 0.81 whereas the PE ratio was 20.30 over 12-month period. Referring to stock’s 52-week performance, its high was $542.07, and the low was $412.00. On the whole, ELV has fluctuated by 3.33% over the past month.
With the market capitalization of Elevance Health Inc currently standing at about $124.87 billion, investors are eagerly awaiting this quarter’s results, scheduled for Apr 18, 2024. The company’s Forward Dividend Ratio is 6.07, with its dividend yield at 1.13%.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ELV’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 1.68, with the price of ELV currently trading nearly 4.44% and 5.13% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 66.89, while the 7-day volatility ratio is showing 1.62% which for the 30-day chart, stands at 1.72%. Furthermore, Elevance Health Inc (ELV)’s beta value is 0.79, and its average true range (ATR) is 9.63.
A comparison of Elevance Health Inc (ELV) with its peers suggests the former has fared considerably weaker in the market. ELV showed an intraday change of -0.45% in last session, and over the past year, it grew by 18.76%%.
Data on historical trading for Elevance Health Inc (NYSE:ELV) indicates that the trading volumes over the past 3 months, they’ve averaged 990.49K. According to company’s latest data on outstanding shares, there are 233.07 million shares outstanding.
Nearly 0.50% of Elevance Health Inc’s shares belong to company insiders and institutional investors own 91.71% of the company’s shares. The stock has risen by 13.93% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ELV stock heading into the next quarter.
